ZNF668 and cancer: In terms of DSS, high ZNF668 expression indicated a poor prognosis in 6 cancer types: BRCA, KIRC, KIRP, LIHC, THCA, and UVM, but predicted a better prognosis in DLBC and ESCA (Figure 4B).